We further analysed the association between AXIN1 and RUNX1 at the protein level using a commercial tumour microarray, TMA-1007, which included among others duplicate cores from 31 ER+ invasive ductal carcinomas in which ER was expressed at either low (ERlow) or high levels (ERhigh). Here, RUNX1 is linked to invasive ductal breast carcinoma.